Cite
HARVARD Citation
Uehara, K. et al. (n.d.). 2016 Early results of phase II trial of perioperative oxaliplatin and capecitabine (XELOX) without radiotherapy for high-risk rectal cancer (CORONA I). European journal of cancer. pp. S333-S334. [Online].